Exact Mass: 496.1852
Exact Mass Matches: 496.1852
Found 238 metabolites which its exact mass value is equals to given mass value 496.1852
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(7R*,8R*)-3-Methoxy-3',4,7,9,9'-pentahydroxy-8,4'-oxyneolignan 4-xyloside
(7R*,8R*)-3-Methoxy-3,4,7,9,9-pentahydroxy-8,4-oxyneolignan 4-xyloside is a constituent of Pinus sylvestris (Scotch pine). Constituent of Pinus sylvestris (Scotch pine)
combretastatin B-1 2-beta-D-glucoside|combretastatin B-1 2-O-beta-D-glucopyranoside
punaglandin 3
3-acetoxy-1,2;8,9-diepoxy-10-hexanoyloxy-2,3,6a,7,9,10,13a,14-octahydro-1H,8H-7a,14a-cyclo-pyrazino[1,2-a;4,5-a]diindole-6,13-dione|O-acetyl-O-hexanoyl-scabrosine|Scabrosin-4-acetat-4-hexanoat
N-Acetyl-D-glucosaminyl-(1-4)-N-acetylmuramic Acid
8alpha-(2-methyl)acryloylxy-13-methoxyvernojalcanolide
3,10-bis-butyryloxy-1,2;8,9-diepoxy-2,3,6a,7,9,10,13a,14-octahydro-1H,8H-7a,14a-cyclo-pyrazino[1,2-a;4,5-a]diindole-6,13-dione|O,O-dibutyryl-scabrosine|Scabrosin-4,4-dibutyrat
Ala Tyr Glu Asp
Glu Tyr Ala Asp
C24H32O11_2-Propenoic acid, 2-methyl-, (4S,6R,6aS,9R,10S,10aR)-6,10-bis(acetyloxy)-4,5,6,6a,7,8,9,10-octahydro-6a,9-dihydroxy-3-(methoxymethyl)-6,9-dimethyl-2-oxo-2H-naphtho[8a,1-b]furan-4-yl ester
Ala Asp Glu Tyr
Ala Asp Tyr Glu
Ala Glu Asp Tyr
Ala Glu Tyr Asp
Ala Tyr Asp Glu
Cys Phe Met Pro
Cys Phe Pro Met
Cys His His Thr
Cys His Thr His
Cys Ile Met Met
Cys Leu Met Met
Cys Met Phe Pro
Cys Met Ile Met
Cys Met Leu Met
Cys Met Met Ile
Cys Met Met Leu
Cys Met Pro Phe
Cys Pro Phe Met
Cys Pro Met Phe
Cys Thr His His
Asp Ala Glu Tyr
Asp Ala Tyr Glu
Asp Asp Phe Thr
Asp Asp Thr Phe
Asp Glu Ala Tyr
Asp Glu Phe Ser
Asp Glu His Pro
Asp Glu Pro His
Asp Glu Ser Phe
Asp Glu Tyr Ala
Asp Phe Asp Thr
Asp Phe Glu Ser
Asp Phe Ser Glu
Asp Phe Thr Asp
Asp His Glu Pro
Asp His Pro Glu
Asp Pro Glu His
Asp Pro His Glu
Asp Ser Glu Phe
Asp Ser Phe Glu
Asp Thr Asp Phe
Asp Thr Phe Asp
Asp Tyr Ala Glu
Asp Tyr Glu Ala
Glu Ala Asp Tyr
Glu Ala Tyr Asp
Glu Asp Ala Tyr
Glu Asp Phe Ser
Glu Asp His Pro
Glu Asp Pro His
Glu Asp Ser Phe
Glu Asp Tyr Ala
Glu Glu Gly Tyr
Glu Glu Tyr Gly
Glu Phe Asp Ser
Glu Phe Ser Asp
Glu Gly Glu Tyr
Glu Gly Tyr Glu
Glu His Asp Pro
Glu His Pro Asp
Glu Pro Asp His
Glu Pro His Asp
Glu Ser Asp Phe
Glu Ser Phe Asp
Glu Tyr Asp Ala
Glu Tyr Glu Gly
Glu Tyr Gly Glu
Phe Cys Met Pro
Phe Cys Pro Met
Phe Asp Asp Thr
Phe Asp Glu Ser
Phe Asp Ser Glu
Phe Asp Thr Asp
Phe Glu Asp Ser
Phe Glu Ser Asp
Phe Met Cys Pro
Phe Met Pro Cys
Phe Pro Cys Met
Phe Pro Met Cys
Phe Ser Asp Glu
Phe Ser Glu Asp
Phe Thr Asp Asp
Gly Glu Glu Tyr
Gly Glu Tyr Glu
Gly Tyr Glu Glu
His Cys His Thr
His Cys Thr His
His Asp Glu Pro
His Asp Pro Glu
His Glu Asp Pro
His Glu Pro Asp
His His Cys Thr
His His Thr Cys
His Pro Asp Glu
His Pro Glu Asp
His Thr Cys His
His Thr His Cys
Ile Cys Met Met
Ile Met Cys Met
Ile Met Met Cys
Leu Cys Met Met
Leu Met Cys Met
Leu Met Met Cys
Met Cys Phe Pro
Met Cys Ile Met
Met Cys Leu Met
Met Cys Met Ile
Met Cys Met Leu
Met Cys Pro Phe
Met Phe Cys Pro
Met Phe Pro Cys
Met Ile Cys Met
Met Ile Met Cys
Met Leu Cys Met
Met Leu Met Cys
Met Met Cys Ile
Met Met Cys Leu
Met Met Ile Cys
Met Met Leu Cys
Met Pro Cys Phe
Met Pro Phe Cys
Asn Asn Ser Tyr
Asn Asn Tyr Ser
Asn Ser Asn Tyr
Asn Ser Tyr Asn
Asn Tyr Asn Ser
Asn Tyr Ser Asn
Pro Cys Phe Met
Pro Cys Met Phe
Pro Asp Glu His
Pro Asp His Glu
Pro Glu Asp His
Pro Glu His Asp
Pro Phe Cys Met
Pro Phe Met Cys
Pro His Asp Glu
Pro His Glu Asp
Pro Met Cys Phe
Pro Met Phe Cys
Ser Asp Glu Phe
Ser Asp Phe Glu
Ser Glu Asp Phe
Ser Glu Phe Asp
Ser Phe Asp Glu
Ser Phe Glu Asp
Ser Asn Asn Tyr
Ser Asn Tyr Asn
Ser Tyr Asn Asn
Thr Cys His His
Thr Asp Asp Phe
Thr Asp Phe Asp
Thr Phe Asp Asp
Thr His Cys His
Thr His His Cys
Tyr Ala Asp Glu
Tyr Ala Glu Asp
Tyr Asp Ala Glu
Tyr Asp Glu Ala
Tyr Glu Ala Asp
Tyr Glu Asp Ala
Tyr Glu Glu Gly
Tyr Glu Gly Glu
Tyr Gly Glu Glu
Tyr Asn Asn Ser
Tyr Asn Ser Asn
Tyr Ser Asn Asn
7Z-punaglandin 3
(7R*,8R*)-3-Methoxy-3',4,7,9,9'-pentahydroxy-8,4'-oxyneolignan 4-xyloside
Benzeneacetic acid, 3-(aminomethyl)-alpha-((hydroxy((1R)-2-methyl-1-(((3-phenylpropyl)sulfonyl)amino)propyl)phosphinyl)methyl)-, (alphaS)-
[(4S,6R,6aS,9R,10S,10aR)-6,10-diacetyloxy-6a,9-dihydroxy-3-(methoxymethyl)-6,9-dimethyl-2-oxo-5,7,8,10-tetrahydro-4H-benzo[h][1]benzofuran-4-yl] 2-methylprop-2-enoate
1-[oxo-[4-oxo-6-[(4-propan-2-ylphenyl)sulfamoyl]-1H-quinolin-3-yl]methyl]-4-piperidinecarboxamide
[3-(4-Nitrophenyl)-4-oxochromen-7-yl] 4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate
(3S)-3-cyano-3-[[[(2S)-1-[(2S)-3,3-dimethyl-1-oxo-2-[[oxo-[4-(trifluoromethyl)phenyl]methyl]amino]butyl]-2-pyrrolidinyl]-oxomethyl]amino]propanoic acid
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1,3-thiazol-2-ylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-[(1-methyl-4-imidazolyl)sulfonyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-[(1-methyl-4-imidazolyl)sulfonyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1,3-thiazol-2-ylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-[(1-methyl-4-imidazolyl)sulfonyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-[(1-methyl-4-imidazolyl)sulfonyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[(1-methyl-4-imidazolyl)sulfonyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[(1-methyl-4-imidazolyl)sulfonyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-[(1-methyl-4-imidazolyl)sulfonyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-[(1-methyl-4-imidazolyl)sulfonyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
beta-D-Glcp3(1-carboxyEt)NAc-(1->4)-beta-D-GlcpNAc
An amino disaccharide consisting of N-acetyl-beta-D-glucosamine, substituted on O-3 with a 1-carboxyethyl group and linked (1->4) to a second N-acetyl-beta-D-glucosamine residue.
(7R*,8R*)-3-Methoxy-3,4,7,9,9-pentahydroxy-8,4-oxyneolignan 4-xyloside
19-Ethenyl-18-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-2,4,6,8,10,15-hexaen-14-one
BMS-309403 (sodium)
BMS-309403 sodium is a potent, orally active, and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor, with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 sodium interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 sodium improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells[1][2][3].
6,10-bis(acetyloxy)-6a,9-dihydroxy-3-(methoxymethyl)-6,9-dimethyl-2-oxo-4h,5h,7h,8h,10h-naphtho[4a,4-b]furan-4-yl 2-methylprop-2-enoate
5-[12-(bromomethylidene)-4-hydroxy-3,6,9-trimethyltetracyclo[6.6.1.0²,⁶.0¹¹,¹⁵]pentadeca-7,11(15)-dien-3-yl]-2-methylpentane-1,2,3,4-tetrol
[(3r,4s,5s)-3,4,5-trihydroxy-6-[2-(1-hydroxy-4-oxocyclohexyl)ethoxy]oxan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
methyl 5,6-bis(acetyloxy)-7-[(1e)-4-chloro-2-hydroxy-2-(octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-ylidene]heptanoate
(3r)-deoxypumiloside
{"Ingredient_id": "HBIN009581","Ingredient_name": "(3r)-deoxypumiloside","Alias": "NA","Ingredient_formula": "C26H28N2O8","Ingredient_Smile": "C=CC1C2CC3C4=NC5=CC=CC=C5C=C4CN3C(=O)C2=COC1OC6C(C(C(C(O6)CO)O)O)O","Ingredient_weight": "496.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5204","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11420564","DrugBank_id": "NA"}